Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-037484

Chief Medical Officer sold 51,914 shares at an average $22.01 ($1,142,375)

  • Chief Medical Officer acquired 87,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Gordon David N. Chief Medical Officer 2021-06-01 Option exercise +87,500 195,992 D
Gordon David N. Chief Medical Officer 2021-06-01 Sale −9,115 $22.71 $207,024 186,877 D
Gordon David N. Chief Medical Officer 2021-06-01 Sale −4,885 $23.57 $115,142 181,992 D
Gordon David N. Chief Medical Officer 2021-06-02 Sale −31,114 $21.50 $668,808 150,878 D
Gordon David N. Chief Medical Officer 2021-06-02 Sale −6,800 $22.26 $151,401 144,078 D
Derivatives
Gordon David N. Chief Medical Officer 2021-06-01 Option exercise · Restricted Stock Units −87,500 0 D
Open-market sales · 51,914 sh · avg $22.01 · $1,142,375
Loading xslF345X03/doc4.xml…